Search research articles
Contact Us
Filters
Showing results (41-50 of 106) with videos related to
Page
of 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2014
Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial
Vinai Gondi, Stephanie L Pugh, Wolfgang A Tome, et al.
Annals of Nuclear Medicine
|
August 11, 2018
Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial
Michael J Seider, Stephanie L Pugh, Corey Langer, et al.
Advances in Radiation Oncology
|
November 24, 2022
Association of Pretreatment Hippocampal Volume With Neurocognitive Function in Patients Treated With Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology/RTOG 0933
Christopher D Abraham, Stephanie L Pugh, Joseph A Bovi, et al.
Neurosurgery
|
April 5, 2018
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes
William A Hall, Stephanie L Pugh, Jeffrey S Wefel, et al.
Journal of Pain and Symptom Management
|
December 1, 2016
Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG Modification
Stephanie L Pugh, Gwen Wyatt, Raimond K W Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2025
A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer
Sebastian Medina, Naoto Tokuyama, Kamal Hammouda, et al.
JAMA Oncology
|
February 15, 2019
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial
Deborah W Bruner, Stephanie L Pugh, W Robert Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2022
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Christina I Tsien, Stephanie L Pugh, Adam P Dicker, et al.
The Journal of Pathology
|
December 11, 2024
Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens
Brennan T Flannery, Howard M Sandler, Priti Lal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 22, 2019
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902
Daniel A Hamstra, Stephanie L Pugh, Herbert Lepor, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 106) with videos related to
Sort By:
Page
of 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2014
Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial
Vinai Gondi, Stephanie L Pugh, Wolfgang A Tome, et al.
Annals of Nuclear Medicine
|
August 11, 2018
Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial
Michael J Seider, Stephanie L Pugh, Corey Langer, et al.
Advances in Radiation Oncology
|
November 24, 2022
Association of Pretreatment Hippocampal Volume With Neurocognitive Function in Patients Treated With Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology/RTOG 0933
Christopher D Abraham, Stephanie L Pugh, Joseph A Bovi, et al.
Neurosurgery
|
April 5, 2018
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes
William A Hall, Stephanie L Pugh, Jeffrey S Wefel, et al.
Journal of Pain and Symptom Management
|
December 1, 2016
Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG Modification
Stephanie L Pugh, Gwen Wyatt, Raimond K W Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2025
A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer
Sebastian Medina, Naoto Tokuyama, Kamal Hammouda, et al.
JAMA Oncology
|
February 15, 2019
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial
Deborah W Bruner, Stephanie L Pugh, W Robert Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2022
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Christina I Tsien, Stephanie L Pugh, Adam P Dicker, et al.
The Journal of Pathology
|
December 11, 2024
Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens
Brennan T Flannery, Howard M Sandler, Priti Lal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 22, 2019
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902
Daniel A Hamstra, Stephanie L Pugh, Herbert Lepor, et al.
Page
of 11